What Are the Prospects for Controlling Hepatitis C?
article has not abstract
Vyšlo v časopise:
What Are the Prospects for Controlling Hepatitis C?. PLoS Med 6(6): e32767. doi:10.1371/journal.pmed.1000096
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000096
Souhrn
article has not abstract
Zdroje
1. World Hepatitis Alliance 2009 World Hepatitis Day. Available: http://www.worldhepatitisday.org/. Accessed 11 May 2009
2. KlenermanP
KimA
2007 HCV–HIV coinfection: Simple messages from a complex disease. PLoS Med 4 e240 doi:10.1371/journal.pmed.0040240
3. HoughtonM
2009 Discovery of the hepatitis C virus. Liver Int 29 Suppl 182 88
4. WakitaT
PietschmannT
KatoT
DateT
MiyamotoM
2005 Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11 791 796
5. SimmondsP
2004 Genetic diversity and evolution of hepatitis C virus—15 years on. J Gen Virol 85 3173 3188
6. PybusOG
CharlestonMA
GuptaS
RambautA
HolmesEC
2001 The epidemic behavior of the hepatitis C virus. Science 292 2323 2325
7. KuikenC
SimmondsP
2009 Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol 510 33 53
8. PybusOG
BarnesE
TaggartR
LemeyP
MarkovPV
2009 Genetic history of hepatitis C virus in East Asia. J Virol 83 1071 1082
9. ZeuzemS
BergT
MoellerB
HinrichsenH
MaussS
2009 Expert opinion on the treatment of patients with chronic hepatitis C. J Viral Hepat 16 75 90
10. Torres-PuenteM
CuevasJM
Jimenez-HernandezN
BrachoMA
Garcia-RoblesI
2008 Genetic variability in hepatitis C virus and its role in antiviral treatment response. J Viral Hepat 15 188 199
11. DrexlerJF
KupferB
PetersenN
GrottoRMT
RodriguesSMC
2009 A novel diagnostic target in the hepatitis C virus genome. PLoS Med 6 e1000031 doi:10.1371/journal.pmed.1000031
12. NagamineK
HaseT
NotomiT
2002 Accelerated reaction by loop-mediated isothermal amplification using loop primers. Mol Cell Probes 16 223 229
13. ThompsonAJ
McHutchisonJG
2009 Review article: Investigational agents for chronic hepatitis C. Aliment Pharmacol Ther 29 689 705
14. ThimmeR
Neumann-HaefelinC
BoettlerT
BlumHE
2008 Adaptive immune responses to hepatitis C virus: From viral immunobiology to a vaccine. Biol Chem 389 457 467
15. Schulze Zur WieschJ
LauerGM
TimmJ
KuntzenT
NeukammM
2007 Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection. Blood 110 1559 1569
16. GaudieriS
RauchA
PfafferottK
BarnesE
ChengW
2009 Hepatitis C virus drug resistance and immune-driven adaptations: Relevance to new antiviral therapy. Hepatology 49 1069 1082
17. BaoY
BolotovP
DernovoyD
KiryutinB
ZaslavskyL
2008 The influenza virus resource at the National Center for Biotechnology Information. J Virol 82 596 601
18. CombetC
PeninF
GeourjonC
DeleageG
2004 HCVDB: Hepatitis C virus sequences database. Appl Bioinformatics 3 237 240
19. Division of AIDS, National Institute of Allergy and Infectious Diseases 2009 HIV databases. Available: http://www.hiv.lanl.gov/. Accessed 11 May 2009
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2009 Číslo 6
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Zástava srdce u pacienta se střelnými ranami – kazuistika
- Statinová intolerance
Najčítanejšie v tomto čísle
- Funding for Reproductive Health in Conflict and Post-Conflict Countries: A Familiar Story of Inequity and Insufficient Data
- In Global Health Research, Is It Legitimate To Stop Clinical Trials Early on Account of Their Opportunity Costs?
- Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses?
- Clean Water Should Be Recognized as a Human Right